Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.
Iannitti RG, Casagrande A, De Luca A, Cunha C, Sorci G, Riuzzi F, Borghi M, Galosi C, Massi-Benedetti C, Oury TD, Cariani L, Russo M, Porcaro L, Colombo C, Majo F, Lucidi V, Fiscarelli E, Ricciotti G, Lass-Flörl C, Ratclif L, Esposito A, De Benedictis FM, Donato R, Carvalho A, Romani L.
Iannitti RG, et al. Among authors: casagrande a.
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1338-50. doi: 10.1164/rccm.201305-0986OC.
Am J Respir Crit Care Med. 2013.
PMID: 24127697